Assessment of genetically modified maize GA21 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐005) - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue EFSA Journal Année : 2017

Assessment of genetically modified maize GA21 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐005)

Hanspeter Naegeli
  • Fonction : Auteur
Andrew Nicholas Birch
  • Fonction : Auteur
Josep Casacuberta
Adinda de Schrijver
  • Fonction : Auteur
Mikołaj Antoni Gralak
  • Fonction : Auteur
Huw Jones
  • Fonction : Auteur
Barbara Manachini
  • Fonction : Auteur
Antoine Messéan
Elsa Ebbesen Nielsen
  • Fonction : Auteur
Fabien Nogué
Christophe Robaglia
  • Fonction : Auteur
Nils Rostoks
  • Fonction : Auteur
Jeremy Sweet
  • Fonction : Auteur
Christoph Tebbe
  • Fonction : Auteur
Francesco Visioli
  • Fonction : Auteur
  • PersonId : 983492
Jean‐michel Wal
  • Fonction : Auteur
Michele Ardizzone
  • Fonction : Auteur
Nikoletta Papadopoulou
  • Fonction : Auteur

Résumé

Following the submission of application EFSA-GMO-RX-005 under Regulation (EC) No 1829/2003 from Syngenta Crop Protection NV/SA, the Panel on Genetically Modified Organisms of the European Food Safety Authority (GMO Panel) was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application of the herbicide-tolerant genetically modified maize GA21. The data received in the context of this renewal application contained post-market environmental monitoring reports, a systematic search and evaluation of literature, updated bioinformatics analyses, and additional documents or studies performed by or on behalf of the applicant. The GMO Panel assessed these data for possible new hazards, modified exposure or new scientific uncertainties identified during the authorisation period and not previously assessed in the context of the original application. Under the assumption that the DNA sequence of the event in maize GA21 considered for renewal is identical to the corrected sequence of the originally assessed event, the GMO Panel concludes that there is no evidence in the renewal application EFSA-GMO-RX-005 for new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment on maize GA21.
Fichier principal
Vignette du fichier
2017_Naegeli_EFSA Journal_15(10).pdf (680.24 Ko) Télécharger le fichier
Origine : Accord explicite pour ce dépôt
Loading...

Dates et versions

hal-01741288 , version 1 (22-03-2018)

Licence

Paternité - Pas de modifications

Identifiants

Citer

Hanspeter Naegeli, Andrew Nicholas Birch, Josep Casacuberta, Adinda de Schrijver, Mikołaj Antoni Gralak, et al.. Assessment of genetically modified maize GA21 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐005). EFSA Journal, 2017, 15 (10), ⟨10.2903/j.efsa.2017.5006⟩. ⟨hal-01741288⟩
44 Consultations
48 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More